These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
329 related items for PubMed ID: 17335007
41. Computational study of bindings of HK20 Fab and D5 Fab to HIV-1 gp41. Hartono YD, Lazim R, Yip YM, Zhang D. Bioorg Med Chem Lett; 2012 Feb 15; 22(4):1695-700. PubMed ID: 22260771 [Abstract] [Full Text] [Related]
42. Study on the inhibitory mechanism and binding mode of the hydroxycoumarin compound NSC158393 to HIV-1 integrase by molecular modeling. Liu M, Cong XJ, Li P, Tan JJ, Chen WZ, Wang CX. Biopolymers; 2009 Sep 15; 91(9):700-9. PubMed ID: 19382173 [Abstract] [Full Text] [Related]
43. Importance of individual side chains for the stability of a protein fold: computational alanine scanning of the insulin monomer. Zoete V, Meuwly M. J Comput Chem; 2006 Nov 30; 27(15):1843-57. PubMed ID: 16981237 [Abstract] [Full Text] [Related]
44. Molecular dynamics simulations of human LRH-1: the impact of ligand binding in a constitutively active nuclear receptor. Burendahl S, Treuter E, Nilsson L. Biochemistry; 2008 May 06; 47(18):5205-15. PubMed ID: 18410128 [Abstract] [Full Text] [Related]
45. Retrocyclin RC-101 overcomes cationic mutations on the heptad repeat 2 region of HIV-1 gp41. Fuhrman CA, Warren AD, Waring AJ, Dutz SM, Sharma S, Lehrer RI, Cole AL, Cole AM. FEBS J; 2007 Dec 06; 274(24):6477-87. PubMed ID: 18028423 [Abstract] [Full Text] [Related]
46. Studies of the mechanism of selectivity of protein tyrosine phosphatase 1B (PTP1B) bidentate inhibitors using molecular dynamics simulations and free energy calculations. Fang L, Zhang H, Cui W, Ji M. J Chem Inf Model; 2008 Oct 06; 48(10):2030-41. PubMed ID: 18831546 [Abstract] [Full Text] [Related]
47. A multistep approach to structure-based drug design: studying ligand binding at the human neutrophil elastase. Steinbrecher T, Case DA, Labahn A. J Med Chem; 2006 Mar 23; 49(6):1837-44. PubMed ID: 16539369 [Abstract] [Full Text] [Related]
48. Application of the lambda-dynamics method to evaluate the relative binding free energies of inhibitors to HCV protease. Guo Z, Durkin J, Fischmann T, Ingram R, Prongay A, Zhang R, Madison V. J Med Chem; 2003 Dec 04; 46(25):5360-4. PubMed ID: 14640544 [Abstract] [Full Text] [Related]
49. Free-energy simulations of the oxidation of c-terminal methionines in calmodulin. Jas GS, Kuczera K. Proteins; 2002 Aug 01; 48(2):257-68. PubMed ID: 12112694 [Abstract] [Full Text] [Related]
50. Development of a FRET assay for monitoring of HIV gp41 core disruption. Xu Y, Hixon MS, Dawson PE, Janda KD. J Org Chem; 2007 Aug 31; 72(18):6700-7. PubMed ID: 17685571 [Abstract] [Full Text] [Related]
51. Kinetic and binding effects in peptide substrate selectivity of matrix metalloproteinase-2: Molecular dynamics and QM/MM calculations. Díaz N, Suárez D, Suárez E. Proteins; 2010 Jan 31; 78(1):1-11. PubMed ID: 19585658 [Abstract] [Full Text] [Related]
52. A computational analysis of the binding affinities of FKBP12 inhibitors using the MM-PB/SA method. Xu Y, Wang R. Proteins; 2006 Sep 01; 64(4):1058-68. PubMed ID: 16838311 [Abstract] [Full Text] [Related]
53. Computational detection of the binding-site hot spot at the remodeled human growth hormone-receptor interface. Verkhivker GM, Bouzida D, Gehlhaar DK, Rejto PA, Freer ST, Rose PW. Proteins; 2003 Nov 01; 53(2):201-19. PubMed ID: 14517972 [Abstract] [Full Text] [Related]
54. Molecular insights into 14-membered macrolides using the MM-PBSA method. Yam WK, Wahab HA. J Chem Inf Model; 2009 Jun 01; 49(6):1558-67. PubMed ID: 19469526 [Abstract] [Full Text] [Related]
55. AGBNP: an analytic implicit solvent model suitable for molecular dynamics simulations and high-resolution modeling. Gallicchio E, Levy RM. J Comput Chem; 2004 Mar 01; 25(4):479-99. PubMed ID: 14735568 [Abstract] [Full Text] [Related]
56. Molecular dynamics simulations of 2-amino-6-arylsulphonylbenzonitriles analogues as HIV inhibitors: interaction modes and binding free energies. Hu R, Barbault F, Maurel F, Delamar M, Zhang R. Chem Biol Drug Des; 2010 Dec 01; 76(6):518-26. PubMed ID: 20942836 [Abstract] [Full Text] [Related]
57. Molecular dynamics study of zinc binding to cysteines in a peptide mimic of the alcohol dehydrogenase structural zinc site. Brandt EG, Hellgren M, Brinck T, Bergman T, Edholm O. Phys Chem Chem Phys; 2009 Feb 14; 11(6):975-83. PubMed ID: 19177216 [Abstract] [Full Text] [Related]
58. Atoms-in-molecules study of the genetically encoded amino acids. III. Bond and atomic properties and their correlations with experiment including mutation-induced changes in protein stability and genetic coding. Matta CF, Bader RF. Proteins; 2003 Aug 15; 52(3):360-99. PubMed ID: 12866050 [Abstract] [Full Text] [Related]
59. A molecular thermodynamic view of DNA-drug interactions: a case study of 25 minor-groove binders. Shaikh SA, Ahmed SR, Jayaram B. Arch Biochem Biophys; 2004 Sep 01; 429(1):81-99. PubMed ID: 15288812 [Abstract] [Full Text] [Related]
60. A predictive method for the evaluation of peptide binding in pocket 1 of HLA-DRB1 via global minimization of energy interactions. Androulakis IP, Nayak NN, Ierapetritou MG, Monos DS, Floudas CA. Proteins; 1997 Sep 01; 29(1):87-102. PubMed ID: 9294869 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]